HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhou Fei Selected Research

Proliferating Cell Nuclear Antigen (PCNA)

12/2005Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas.
2/2005The effect of cyclin D expression on cell proliferation in human gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhou Fei Research Topics

Disease

34Glioma (Gliomas)
11/2023 - 02/2005
29Neoplasms (Cancer)
06/2023 - 03/2002
23Traumatic Brain Injuries (Traumatic Brain Injury)
07/2022 - 11/2007
16Brain Ischemia (Cerebral Ischemia)
11/2023 - 08/2010
13Ischemia
11/2023 - 08/2010
11Glioblastoma (Glioblastoma Multiforme)
06/2023 - 11/2009
8Mitochondrial Diseases (Mitochondrial Disease)
12/2021 - 10/2010
8Brain Edema (Cerebral Edema)
01/2019 - 10/2010
7Brain Injuries (Brain Injury)
12/2023 - 06/2005
6Inflammation (Inflammations)
11/2023 - 02/2011
6Wounds and Injuries (Trauma)
04/2023 - 08/2004
6Infarction (Infarctions)
01/2016 - 12/2010
6Diffuse Brain Injuries (Diffuse Brain Injury)
11/2007 - 10/2003
5Reperfusion Injury
07/2024 - 01/2013
5Ischemic Stroke
01/2024 - 12/2010
5Carcinogenesis
01/2016 - 02/2005
4Hypoxia (Hypoxemia)
10/2023 - 01/2013
4Hemorrhage
03/2022 - 09/2003
4Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 10/2010
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2023 - 12/2010
3Neuroinflammatory Diseases
04/2023 - 01/2019
3Hematoma
11/2022 - 11/2015
3Cerebral Hemorrhage
05/2022 - 01/2013
3Neurologic Manifestations (Neurological Manifestations)
07/2014 - 01/2013
3Parkinson Disease (Parkinson's Disease)
12/2013 - 10/2010
3Pituitary Neoplasms (Pituitary Adenoma)
09/2010 - 06/2005
2Central Nervous System Diseases (CNS Diseases)
12/2023 - 07/2011
2Diffuse Axonal Injury
01/2023 - 02/2000
2Lymphoma (Lymphomas)
02/2020 - 01/2013
2Dehydration (Water Stress)
01/2019 - 01/2014
2Chronic Subdural Hematoma
11/2018 - 11/2015
2Nervous System Diseases (Neurological Disorders)
01/2017 - 11/2015
2Brain Contusion
01/2017 - 01/2015
2Seizures (Absence Seizure)
01/2017 - 01/2013
2Meningioma (Meningiomas)
03/2015 - 12/2012
2Edema (Dropsy)
07/2014 - 12/2010
2Cerebral Infarction
07/2014 - 04/2012
2Pain (Aches)
01/2013 - 10/2012
2Astrocytoma (Pilocytic Astrocytoma)
09/2011 - 06/2010
2Stroke (Strokes)
07/2011 - 12/2010
2Hypotension (Low Blood Pressure)
11/2007 - 10/2003
2Craniocerebral Trauma (Head Injury)
08/2004 - 10/2003

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
04/2024 - 12/2005
12Neuroprotective AgentsIBA
07/2022 - 10/2010
8Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
10/2012 - 10/2003
7Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2007
7Caspase 3 (Caspase-3)IBA
05/2022 - 02/2007
6Messenger RNA (mRNA)IBA
06/2023 - 06/2005
65-methoxy-methylindoleacetic acid (DBI)IBA
11/2007 - 10/2003
5Retinaldehyde (Retinal)IBA
07/2024 - 10/2015
5Glutamic Acid (Glutamate)FDA Link
01/2022 - 08/2010
5CalciumIBA
11/2020 - 08/2010
4Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2013
4SaponinsIBA
07/2016 - 01/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 07/2011
4ResveratrolIBA
08/2014 - 02/2007
3alloseIBA
10/2023 - 01/2013
3Hematoxylin (Haematoxylon)IBA
04/2023 - 03/2002
3Eosine Yellowish-(YS) (Eosin)IBA
04/2023 - 03/2002
3Indicators and Reagents (Reagents)IBA
01/2023 - 04/2011
3Temozolomide (Temodar)FDA LinkGeneric
09/2022 - 03/2015
3Homer Scaffolding Proteins (Homer 1)IBA
07/2022 - 06/2012
3CytokinesIBA
03/2022 - 02/2011
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
3Oxygen (Dioxygen)IBA
01/2018 - 02/2015
3Small Interfering RNA (siRNA)IBA
11/2015 - 11/2007
3Matrix Metalloproteinases (MMPs)IBA
01/2015 - 06/2012
3Cytochromes c (Cytochrome c)IBA
06/2014 - 06/2012
3osthol (osthole)IBA
12/2013 - 10/2010
3Adenosine Triphosphate (ATP)IBA
10/2013 - 06/2012
3Caspase 9IBA
04/2013 - 02/2010
2NestinIBA
12/2023 - 03/2022
2AntigensIBA
06/2023 - 04/2016
2IronIBA
11/2022 - 01/2019
2Sirtuin 3IBA
05/2022 - 01/2017
2Excitatory Amino AcidsIBA
11/2020 - 08/2010
2Minocycline (Cyclops)FDA LinkGeneric
01/2019 - 01/2013
2Mannitol (Osmitrol)FDA LinkGeneric
01/2019 - 01/2014
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 08/2014
2Atorvastatin (Lipitor)FDA Link
11/2018 - 11/2015
2Interleukin-8 (Interleukin 8)IBA
01/2015 - 12/2010
2diazonaphthalenedisulfonic acid (NDS)IBA
07/2014 - 12/2010
2triphenyltetrazoliumIBA
07/2014 - 12/2010
2N-Methylaspartate (NMDA)IBA
06/2014 - 01/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
06/2014 - 10/2010
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2014 - 10/2012
2U 0126 (UO 126)IBA
06/2014 - 11/2011
2NeurotoxinsIBA
01/2013 - 10/2010
2Superoxides (Superoxide)IBA
01/2013 - 04/2012
2SurvivinIBA
11/2007 - 12/2005
2Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2005 - 02/2005

Therapy/Procedure

18Therapeutics
11/2023 - 01/2007
3Drug Therapy (Chemotherapy)
01/2013 - 08/2007
3Neuroendoscopes
09/2010 - 06/2005
2Immunotherapy
06/2023 - 04/2016
2Transcranial Magnetic Stimulation
01/2023 - 01/2023
2Craniotomy
12/2022 - 09/2003
2Biological Therapy
02/2012 - 09/2011
2Radiotherapy
01/2011 - 08/2007
2Endoscopes
09/2010 - 06/2005